NCT00339183 Comparison of Treatment Effect of Chemotherapy With Panitumumab to Chemotherapy Alone Status COMPLETED Phase PHASE3
NCT00332163 Skin Toxicity Treatment in Metastatic Colorectal Cancer (mCRC) Patients Receiving Panitumumab + Irinotecan-based Therapy Status COMPLETED Phase PHASE2
NCT00313872 Phase III Trial of DP Followed by FOLFIRI or the Reverse Sequence in Unresectable Gastric Cancer Status COMPLETED Phase PHASE3
NCT00286130 Safety and Efficacy of Folfox6 + Cetuximab Versus Folfiri +Cetuximab in Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE2
NCT00265850 Cetuximab and/or Bevacizumab Combined With Combination Chemotherapy in Treating Patients With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT00208260 Intensified Chemotherapy in CRC After Resection of Liver Metastases Status COMPLETED Phase PHASE2/PHASE3
NCT00101894 Safety of AMG 706 Plus Panitumumab Plus Chemotherapy in the Treatment of Subjects With Metastatic Colorectal Cancer Status COMPLETED Phase PHASE1